Three people were charged with conspiring with others to have unqualified people admitted to skilled nursing homes and assisted living facilities. » Read More
Citron's Andrew Left says he does not think Valeant shares will trade above $60 anytime soon.
Shortly after releasing its initial results, Perrigo revised its net loss figures to be lower than originally stated.
Since 2011, the percentage of Americans who lack health insurance has fallen by 6 percentage points.
Spending on children's health care grew annually by an average of 5.1 percent from 2010 to 2014, mainly due to price hikes.
A new study released Monday found that 45 percent of heart attacks in the United States are "silent" — the people having them don't realize.
Employers around the country say they are struggling to find workers who can pass a pre-employment drug test, The New York Times reports.
A campaign to raise California's cigarette tax by $2 a pack said it has collected enough signatures to qualify the proposal for the Nov. 8 ballot.
Valeant said on Monday it would make available to all hospitals in the U.S. an enhanced rebate program to reduce the price of Nitropress and Isuprel.
Pfizer will buy Anacor Pharmaceuticals in a deal valued at $5.2 billion, for access to Anacor's non-steroidal topical gel to treat eczema.
The case involves a man whose wife died of a lung cancer-related brain tumor after smoking the company's low-tar cigarettes.
Pfizer announced controls on the distribution of its products to ensure that none are used in lethal injections, the New York Times reports.
Allergan rose nearly 3 percent after Goldman Sachs released a very bullish note on the stock.
Intrexon is ready to fight the Zika virus and believes it will get approval to do so in the U.S., its CEO says.
Researchers at MIT have designed an ingestible "robot" that can unfold inside the body, The Verge reports.
Sanofi will nominate eight people to replace the board of Medivation, sources say.
The court case challenges the legality of payments the Obama administration makes to insurers.
Shares of Valeant fell nearly 6 percent after the New York Times reported the company has not kept the discount promises it made to Congress.
There is also strong opposition to speeding up the federal drug approval process, a new poll finds.
The study said when people took acetaminophen, Tylenol's main ingredient, they were less likely to empathize with people experiencing pain. The USAToday reports.
Aetna said it plans to continue its Obamacare health insurance business next year in the 15 states where it now participates, and may expand.
Get the best of CNBC in your inbox